Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1980
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 1
1985 1
1987 1
1988 1
1989 4
1992 3
1993 3
1994 1
1995 1
1996 1
1999 1
2000 2
2001 4
2002 1
2003 5
2004 6
2005 4
2006 4
2007 4
2008 8
2009 4
2010 13
2011 7
2012 11
2013 5
2014 6
2015 9
2016 14
2017 7
2018 17
2019 15
2020 7
2021 8
2022 9
2023 7
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Patent Ductus Arteriosus of the Preterm Infant.
Hamrick SEG, Sallmon H, Rose AT, Porras D, Shelton EL, Reese J, Hansmann G. Hamrick SEG, et al. Pediatrics. 2020 Nov;146(5):e20201209. doi: 10.1542/peds.2020-1209. Pediatrics. 2020. PMID: 33093140 Free PMC article. Review.
A persistently patent ductus arteriosus (PDA) in preterm infants can have clinical consequences. Decreasing pulmonary vascular resistance, especially in extremely low gestational age newborns, increases left-to-right shunting through the ductus and increases …
A persistently patent ductus arteriosus (PDA) in preterm infants can have clinical consequences. Decreasing pulmonary vascular …
Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis.
Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, Zea AM, Zhang Y, Sadeghirad B, Thabane L. Mitra S, et al. JAMA. 2018 Mar 27;319(12):1221-1238. doi: 10.1001/jama.2018.1896. JAMA. 2018. PMID: 29584842 Free PMC article. Review.
IMPORTANCE: Despite increasing emphasis on conservative management of patent ductus arteriosus (PDA) in preterm infants, different pharmacotherapeutic interventions are used to treat those developing a hemodynamically significant PDA. ...MAIN OUTCOMES AND MEASURES: …
IMPORTANCE: Despite increasing emphasis on conservative management of patent ductus arteriosus (PDA) in preterm infants, diffe …
Understanding the Pathophysiology, Implications, and Treatment Options of Patent Ductus Arteriosus in the Neonatal Population.
Conrad C, Newberry D. Conrad C, et al. Adv Neonatal Care. 2019 Jun;19(3):179-187. doi: 10.1097/ANC.0000000000000590. Adv Neonatal Care. 2019. PMID: 30720481 Review.
BACKGROUND: Patent ductus arteriosus (PDA) is the persistence of a fetal shunt between the pulmonary artery and the aorta. This structure normally closes in the first 3 days after birth; however, closure is delayed in up to 80% of infants born at 25 to …
BACKGROUND: Patent ductus arteriosus (PDA) is the persistence of a fetal shunt between the pulmonary artery and the aorta. Thi …
Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews.
Mitra S, de Boode WP, Weisz DE, Shah PS. Mitra S, et al. Cochrane Database Syst Rev. 2023 Apr 11;4(4):CD013588. doi: 10.1002/14651858.CD013588.pub2. Cochrane Database Syst Rev. 2023. PMID: 37039501 Free PMC article. Review.
BACKGROUND: Patent ductus arteriosus (PDA) is associated with significant morbidity and mortality in preterm infants. ...Oral ibuprofen appears to be more effective in PDA closure than IV ibuprofen (moderate-certainty evidence). High dose ibuprofen appears to …
BACKGROUND: Patent ductus arteriosus (PDA) is associated with significant morbidity and mortality in preterm infants. ...Oral …
Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider.
Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, Mah ML, Bhombal S, Smith CV, McNamara PJ, Benitz WE, Garg V. Backes CH, et al. J Am Heart Assoc. 2022 Sep 6;11(17):e025784. doi: 10.1161/JAHA.122.025784. Epub 2022 Sep 3. J Am Heart Assoc. 2022. PMID: 36056734 Free PMC article. Review.
The burden of patent ductus arteriosus (PDA) continues to be significant. In view of marked differences in preterm infants versus more mature, term counterparts (viewed on a continuum with adolescent and adult patients), mechanisms regulating ductal patency, genetic …
The burden of patent ductus arteriosus (PDA) continues to be significant. In view of marked differences in preterm infants ver …
Therapeutic strategy of patent ductus arteriosus in extremely preterm infants.
Su BH, Lin HY, Chiu HY, Tsai ML, Chen YT, Lu IC. Su BH, et al. Pediatr Neonatol. 2020 Apr;61(2):133-141. doi: 10.1016/j.pedneo.2019.10.002. Epub 2019 Oct 29. Pediatr Neonatol. 2020. PMID: 31740267 Free article. Review.

The ductus arteriosus is likely to close without treatment in most infants born at gestational age (GA) > 28 weeks (73%), and those with birth weight > 1000 g (94%). ...Extremely preterm infants born at GA < 28 weeks are associated with a high risk o

The ductus arteriosus is likely to close without treatment in most infants born at gestational age (GA) > 28 weeks (73%), a …
Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn.
Antonucci R, Zaffanello M, Puxeddu E, Porcella A, Cuzzolin L, Pilloni MD, Fanos V. Antonucci R, et al. Curr Drug Metab. 2012 May 1;13(4):474-90. doi: 10.2174/138920012800166607. Curr Drug Metab. 2012. PMID: 22299823 Review.
Conversely, exposure to NSAIDs after 30 weeks' gestation is associated with an increased risk of premature closure of the fetal ductus arteriosus and oligohydramnios. Fetal and neonatal adverse effects affecting the brain, kidney, lung, skeleton, gastr …
Conversely, exposure to NSAIDs after 30 weeks' gestation is associated with an increased risk of premature closure of the feta …
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.
Jasani B, Mitra S, Shah PS. Jasani B, et al. Cochrane Database Syst Rev. 2022 Dec 15;12:CD010061. doi: 10.1002/14651858.CD010061.pub5. Cochrane Database Syst Rev. 2022. PMID: 36519620 Review.
BACKGROUND: The different management strategies for patent ductus arteriosus (PDA) in preterm infants are expectant management, surgery, or medical treatment with non-selective cyclo-oxygenase inhibitors. ...Thus, establishing the efficacy and safety of paracetamol …
BACKGROUND: The different management strategies for patent ductus arteriosus (PDA) in preterm infants are expectant management …
Definitive Closure of the Patent Ductus Arteriosus in Preterm Infants and Subsequent Short-Term Respiratory Outcomes.
Wheeler CR, Vogel ER, Cusano MA, Friedman KG, Callahan R, Porras D, Ibla JC, Levy PT. Wheeler CR, et al. Respir Care. 2022 May;67(5):594-606. doi: 10.4187/respcare.09489. Respir Care. 2022. PMID: 35473850 Free article. Review.
A persistent patent ductus arteriosus (PDA) can have significant clinical consequences in preterm infants, depending on the degree of left-to-right shunting, its impact on cardiac performance, and associated perinatal risk factors that can mitigate or exacerbate the …
A persistent patent ductus arteriosus (PDA) can have significant clinical consequences in preterm infants, depending on the de …
Echocardiography of the patent ductus arteriosus in premature infant.
Paudel G, Joshi V. Paudel G, et al. Congenit Heart Dis. 2019 Jan;14(1):42-45. doi: 10.1111/chd.12703. Congenit Heart Dis. 2019. PMID: 30811799 Review.
Management of the patent ductus arteriosus (PDA) in the premature infant has been a point of controversy for decades as smaller and earlier gestational age infants have been surviving. Increasing experience with catheter-based device closure has genera …
Management of the patent ductus arteriosus (PDA) in the premature infant has been a point of controversy for decades as …
183 results